Related Experiment Video
Updated: Dec 19, 2025
07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
6.4K
Synchronous Double Bile Duct Cancers with Distinct Genetic Features
Shinichi Morita1, Takeshi Suda1, Yoji Kishi2,3
1Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine Niigata University Hospital, Japan.
Internal Medicine (Tokyo, Japan)
|June 5, 2020
Summary
This study reports a rare case of synchronous double bile duct cancers in a 69-year-old man. Genetic analysis suggests diverse pathways contribute to bile duct cancer development.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Bile duct cancer (cholangiocarcinoma) is a challenging malignancy.
- Synchronous double primary tumors in the bile duct are exceptionally rare.
Observation:
- A 69-year-old male presented with appetite loss and was found to have two distinct bile duct tumors.
- Imaging revealed a nodular perihilar lesion and a flat distal lesion.
- Surgical resection (right hepatopancreaticoduodenectomy) confirmed two separate adenocarcinomas.
Findings:
- Histopathology showed moderately and poorly differentiated adenocarcinoma at different locations.
- No evidence of pancreaticobiliary maljunction was found.
- TP53 gene analysis was performed on both tumors.
Implications:
- This case highlights the potential for multiple, distinct genetic pathways in bile duct cancer pathogenesis.
- Understanding these diverse pathways is crucial for developing targeted therapies.
- The findings underscore the complexity of bile duct cancer development.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
14.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
02:18Cancer
53.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.2K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K